What is it? Why is it important?

A risk-based Quality Management System (QMS) sets its focus on the identification and managment of potential study risks instead of implementing a “one size fits all QMS”.

A risk-based QMS entails that researchers proactively implement a Quality by Design (QbyD) approach, focusing on the study`s Critical to Quality (CtoQ) factors to ensure the:

  • Rights and safety of study participants
  • Ability to answer the research question by generating reliable, interpretable, and meaningful study results

 

A risk-based QMS may include a risk-based:

 

The establishment of a risk-based QMS should be fit for purpose, and proportional to the data being collected and the risk to study participants.

More

A risk-based QMS represents a set of activities, processes, implemented measures to ensure:

What do I need to do?

As a SP-INV:

  • Establish a fit for purpose risk-based QMS, that is operationally feasible. Abstain from introducing of unnecessary complexity
  • Use a QbyD approach, which includes the identification of CtoQ factors
  • Identify risks threatening the integrity of the study`s CtoQ factors and implement applicable risk control-measures
  • Maintain a risk-based QMS throughout all study phases, including study archiving
  • Apply processes that ensure ongoing review of CtoQ factors and applicable risk control measures during study conduct, analysis and reporting
  • In multi-centre studies ensure the site (e.g. Site-INV, site staff) remains trained and comply with QMS requirements

 

As a Site-INV, get an overview of the current QMS status at your site:

  • Train study staff on the implemented risk-based QMS
  • Check if staff qualifications, CVs and certificates are up-to-date (e.g. GCP)
  • Check if study relevant SOPs are current, available, and trained
  • Ensure site infrastructures are able to accommodate study requirements (e.g. IMP / IMD handling, work space, storage of biological material)

Where can I get help?

Your local Research Support Centre can assist you with experienced staff regarding this topic

  • Basel, Departement Klinische Forschung (DKF), dkf.unibas.ch

  • Lugano, Clinical Trials Unit (CTU-EOC), ctueoc.ch

  • Bern, Department of Clinical Research (DCR), dcr.unibe.ch

  • Geneva, Clinical Research Center (CRC), crc.hug.ch

  • Lausanne, Clinical Research Center (CRC), chuv.ch

  • St. Gallen, Clinical Trials Unit (CTU), h-och.ch

  • Zürich, Clinical Trials Center (CTC), usz.ch

References

ICH GCP E6(R2) – see in particular ICH GCP principles and guidelines

  • Main principle: Quality by design should be implemented to identify factors critical to trial quality
  • Principle 6. Quality should be built into the scientific, operational design, and conduct of the trial
  • 3.10 Quality management
  • 3.11 Quality assurance and control assurance

ICH E8(R1) – General 2.2 Scientific approach in clinical study design

  • 3. Designing quality into clinical studies
  • 3.1 Quality by design of clinical studies
  • 5. Design elements and data sources for clinical studies

ISO 9001:2015 (access liable to costs) – see in particular section

  • Quality Management Systems

Documents

 

Abbreviations
  • CtoQ - critical-to-quality
  • CTU – Clinical Trials Unit
  • IMP/IMD – Investigational Medicinal Product / Investigational Medical Device
  • CV – Curriculum Vita
  • GCP – Good Clinical Practice
  • ICH GCP – International Council for Harmonisation Good Clinical Practice
  • ISO – International Organization for Standardization
  • QbyD - Quality by Design
  • QMS – Quality Management System
  • Site-INV – Site-Investigator
  • SOP – Standard Operating Procedures
  • SP-INV – Sponsor-Investigator
Basic ↦ Quality and Risk ↦ Quality Requirements ↦ Risk-Based Quality Management System
Study
Basic

Provides some background knowledge and basic definitions

Basic Monitoring
Concept

Starts with a study idea

Ends after having assessed and evaluated study feasibility

Concept Statistic Methodology
Concept Drug or Device
Development

Starts with confidence that the study is feasible

Ends after having received ethics and regulatory approval

Development Drug or Device
Set-Up

Starts with ethics and regulatory approval

Ends after successful study initiation

Set-Up Ethics and Laws
Set-Up Statistic Methodology
Set-Up Quality and Risk
Set-Up Drug or Device
Conduct

Starts with participant recruitment

Ends after the last participant has completed the last study visit

Conduct Statistic Methodology
Conduct Drug or Device
Completion

Starts with last study visit completed

Ends after study publication and archiving

Completion Drug or Device
Current Path (click to copy): Basic ↦ Quality and Risk ↦ Quality Requirements ↦ Risk-Based Quality Management System